Risk assessment and pancreatic cancer: Diagnostic management and artificial intelligence

V Granata, R Fusco, SV Setola, R Galdiero… - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic cancer (PC) is one of the deadliest cancers. Its high mortality
rate is correlated with several explanations; the main one is the late disease stage at which …

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics

V Granata, R Fusco, SV Setola, R Galdiero… - Infectious agents and …, 2023 - Springer
In this narrative review, we reported un up-to-date on the role of radiomics to assess
prognostic features, which can impact on the liver metastases patient treatment choice. In …

Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment

V Granata, R Fusco, F De Muzio, MC Brunese… - La radiologia …, 2023 - Springer
Objective The aim of this study was the evaluation radiomics analysis efficacy performed
using computed tomography (CT) and magnetic resonance imaging in the prediction of …

Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: Preliminary data using a quantitative tool

D Franco, V Granata, R Fusco, R Grassi, V Nardone… - La radiologia …, 2023 - Springer
Purpose The quantification of radiotherapy (RT)-induced functional and morphological brain
alterations is fundamental to guide therapeutic decisions in patients with brain tumors. The …

A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls

F De Muzio, F Grassi, F Dell'Aversana, R Fusco… - Diagnostics, 2022 - mdpi.com
Liver cancer is the sixth most detected tumor and the third leading cause of tumor death
worldwide. Hepatocellular carcinoma (HCC) is the most common primary liver malignancy …

Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence

V Granata, R Fusco, F De Muzio, C Cutolo, F Grassi… - Biology, 2023 - mdpi.com
Simple Summary The only curative treatment for intrahepatic cholangiocarcinoma (iCCA) is
surgical resection, and an early diagnosis is the most effective way to improve survival. In …

Immunotherapy Assessment: A New Paradigm for Radiologists

V Granata, R Fusco, SV Setola, I Simonetti, C Picone… - Diagnostics, 2023 - mdpi.com
Immunotherapy denotes an exemplar change in an oncological setting. Despite the effective
application of these treatments across a broad range of tumors, only a minority of patients …

[HTML][HTML] Current challenges and future direction in surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

G Cholankeril, HB El-Serag - Seminars in Liver Disease, 2023 - thieme-connect.com
The burden for hepatocellular carcinoma (HCC) attributed to nonalcoholic fatty liver disease
(NAFLD) continues to grow in parallel with rising global trends in obesity. The risk of HCC is …

Imaging in hepatocellular carcinoma: what's New?

G Grazzini, G Chiti, G Zantonelli, B Matteuzzi… - Seminars in Ultrasound …, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is the most common liver cancer and is one of the
uppermost 2 causes of cancer death. About 70%-90% of HCCs develop within a cirrhotic …

Imaging-based characterization of tumoral heterogeneity for personalized cancer treatment

F Haag, A Hertel, H Tharmaseelan… - RöFo-Fortschritte auf …, 2023 - thieme-connect.com
With personalized tumor therapy, understanding and addressing the heterogeneity of
malignant tumors is becoming increasingly important. Heterogeneity can be found within …